✦ LIBER ✦

Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: A pathologic analysis

✍ Scribed by Denton, Mark D.; Magee, Colm C.; Ovuworie, Cyril; Mauiyyedi, Shamila; Pascual, Manuel; Colvin, Robert B.; Cosimi, A. Benedict; Tolkoff-Rubin, Nina

Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 816 KB
Volume: 61
Category: Article
ISSN: 0085-2538
DOI: 10.1046/j.1523-1755.2002.00374.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective analysis of circulating endo

Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma

✍ Andrew L. Feldman; H. Richard Alexander Jr.; James C. Yang; W. Marston Linehan; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract ## BACKGROUND The aim of the current study was to assess circulating levels of endogenous endostatin in patients with renal carinoma and to determine the relationship of these levels to circulating levels of vascular endothelial growth factor (VEGF) and prognosis. ## METHODS The auth

Prevalence and predictive value of p53 m

Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinico-pathological study and survival analysis of 70 patients

✍ King Y. Lam; Sai W. Tsao; Dekai Zhang; Simon Law; Dan He; Lily Ma; John Wong 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 220 KB 👁 2 views

The tissues from 70 Chinese patients with oesophageal squamous cell carcinoma were prospectively collected to study for the pattern of p53 mutations and its relationship with clinico-pathological features and prognosis using immunohistochemistry, polymerase chain reaction-single strand conformationa

Elevated levels of serum aldolase A in p

Elevated levels of serum aldolase A in patients with renal cell carcinoma

✍ Takashi, M. ;Zhu, Y. ;Nakano, Y. ;Miyake, K. ;Kato, K. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 371 KB

To clarify whether serum aldolase A is a useful biomarker for renal cell carcinoma (RCC), we determined serum levels of the aldolase A isozyme by an enzyme immunoassay in patients suffering from RCC, other urological tumors, and benign urological diseases. Forty-six of 126 patients with RCC (37%) ha

Percentage of high-grade carcinoma as a

Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma

✍ Maria F. Serrano; Matthew Katz; Yan Yan; Adam S. Kibel; Peter A. Humphrey 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

A pilot study of thalidomide in patients

A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma

✍ Danai D. Daliani; Christos N. Papandreou; Peter F. Thall; Xuemei Wang; Cherie Pe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Background: The highly vascular nature of renal cell carcinoma (rcc) suggests that angiogenesis inhibition may be therapeutic for patients with this disease. thalidomide inhibits basic fibroblast growth factor and vascular endothelial growth factor (vegf)-induced angiogenesis. ## Methods: In a

A Phase II study of irinotecan in patien

A Phase II study of irinotecan in patients with advanced renal cell carcinoma

✍ Karim Fizazi; Frédéric Rolland; Christine Chevreau; Jean-Pierre Droz; Dominique 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 3 views

## Abstract ## BACKGROUND Patients with disseminated renal cell carcinoma (RCC) have a poor outcome, and the disease is considered highly resistant to chemotherapy. Irinotecan is an active drug in the treatment of a number of neoplastic diseases and is not concerned with the multidrug‐resistance p